Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-2
DOI: 10.2147/dddt.s666928 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Xin Zhou. Beteiligte Einrichtung: Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Xin ZhouDepartment of Chemoradiotherapy, The Affiliated People’s Hospital of Ningbo University, Ningbo, People’s Republic of ChinaCorrespondence: Xin Zhou, The Affiliated People’s Hospital of Ningbo University, Ningbo, Zhejiang, People’s Republic of China, Email Zhou_TF1217@126.com
Autor:innen und Institutionen
- Department of Chemoradiotherapy, The Affiliated People's Hospital of Ningbo University, Ningbo, People's Republic of China.
Zitieren
APA
Zhou, X. (2026). Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]. Drug Design, Development and Therapy, Volume 20, 1-2. https://doi.org/10.2147/dddt.s666928
Vancouver
Zhou X. Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]. Drug Design, Development and Therapy. 2026;Volume 20:1-2. doi:10.2147/dddt.s666928
BibTeX
@article{Zhou2026,
author = {Zhou, Xin},
title = {Misclassification and Circular Inference Undermine the Reported NATALEE Benchmark [Letter]},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--2},
doi = {10.2147/dddt.s666928}
}
EUVIMED